[HTML][HTML] AN698/40746067 suppresses bone marrow adiposity to ameliorate hyperlipidemia-induced osteoporosis through targeted inhibition of ENTR1
H Ren, K Mao, X Yuan, Y Mu, S Zhao, X Fan… - Biomedicine & …, 2024 - Elsevier
Hyperlipidemia-induced osteoporosis is marked by increased bone marrow adiposity, and
treatment with statins for hyperlipidemia often leads to new-onset osteoporosis. Endosome …
treatment with statins for hyperlipidemia often leads to new-onset osteoporosis. Endosome …
AN698/40746067 suppresses bone marrow adiposity to ameliorate hyperlipidemia-induced osteoporosis through targeted inhibition of ENTR1
H Ren, K Mao, X Yuan, Y Mu, S Zhao… - Biomedicine & … - pubmed.ncbi.nlm.nih.gov
Hyperlipidemia-induced osteoporosis is marked by increased bone marrow adiposity, and
treatment with statins for hyperlipidemia often leads to new-onset osteoporosis. Endosome …
treatment with statins for hyperlipidemia often leads to new-onset osteoporosis. Endosome …
AN698/40746067 suppresses bone marrow adiposity to ameliorate hyperlipidemia-induced osteoporosis through targeted inhibition of ENTR1.
H Ren, K Mao, X Yuan, Y Mu, S Zhao… - Biomedicine & …, 2024 - europepmc.org
Hyperlipidemia-induced osteoporosis is marked by increased bone marrow adiposity, and
treatment with statins for hyperlipidemia often leads to new-onset osteoporosis. Endosome …
treatment with statins for hyperlipidemia often leads to new-onset osteoporosis. Endosome …